Tiziana Dell’Anna

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Even if ovarian cancer patients are very responsive to a cisplatinum-based therapy, most will relapse with a resistant disease. New experimental animal models are needed to explore the mechanisms of(More)
  • 1